{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:36:53Z","timestamp":1761763013850},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.urology.2014.01.031","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T17:00:40Z","timestamp":1396544440000},"page":"1350-1355","source":"Crossref","is-referenced-by-count":12,"title":["Findings at Cystoscopy Performed for Cause After Prostate Brachytherapy"],"prefix":"10.1016","volume":"83","author":[{"given":"Michael S.","family":"Leapman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson N.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2014.01.031_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cncr.26307","article-title":"Outcomes after prostate brachytherapy are even better than predicted","volume":"118","author":"Frank","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2014.01.031_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q","article-title":"Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma","volume":"83","author":"Ragde","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2014.01.031_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11934-011-0183-3","article-title":"Update on prostate brachytherapy: long-term outcomes and treatment-related morbidity","volume":"12","author":"Kao","year":"2011","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2014.01.031_bib4","first-page":"808","article-title":"Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy","volume":"173","author":"Kollmeier","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.01.031_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1464-410X.2006.06398.x","article-title":"Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation","volume":"98","author":"Lehrer","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.01.031_bib6","first-page":"141","article-title":"Long-term urinary sequelae following 125-iodine prostate brachytherapy","volume":"179","author":"Crook","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"4A Suppl","key":"10.1016\/j.urology.2014.01.031_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0090-4295(98)00050-8","article-title":"Comprehensive patient evaluation for benign prostatic hyperplasia","volume":"51","author":"Jepsen","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2014.01.031_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00042307-200107000-00010","article-title":"Voiding dysfunction: definitions","volume":"11","author":"Chaikin","year":"2001","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2014.01.031_bib9","first-page":"953","article-title":"Patient reported complications after prostate brachytherapy","volume":"166","author":"Han","year":"2001","journal-title":"J\u00a0Urol"},{"issue":"Suppl 3","key":"10.1016\/j.urology.2014.01.031_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1464-410X.2009.08371.x","article-title":"The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS","volume":"103","author":"Coyne","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.01.031_bib11","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ijrobp.2004.01.050","article-title":"Factors predicting for urinary incontinence after prostate brachytherapy","volume":"59","author":"McElveen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2014.01.031_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.urology.2009.04.060","article-title":"Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience","volume":"74","author":"Anderson","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2014.01.031_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10552-004-8023-0","article-title":"Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia)","volume":"16","author":"Heard","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urology.2014.01.031_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0360-3016(95)00521-Y","article-title":"A\u00a0modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation","volume":"32","author":"Stock","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2014.01.031_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","article-title":"Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2014.01.031_bib16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1464-410X.2006.06491.x","article-title":"The pathophysiology of lower urinary tract symptoms after brachytherapy for prosate cancer","volume":"98","author":"Blaivas","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.01.031_bib17","first-page":"1376","article-title":"Risk factors for the development of prostate brachytherapy related urethral strictures","volume":"175","author":"Merrick","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.01.031_bib18","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1200\/JCO.2011.35.0991","article-title":"Prostate brachytherapy and second primary cancer risk: a competitive risk analysis","volume":"29","author":"Hinnen","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2014.01.031_bib19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2014.01.031_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1667\/RR1219.1","article-title":"Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer","volume":"170","author":"Burri","year":"2008","journal-title":"Radiat Res"},{"key":"10.1016\/j.urology.2014.01.031_bib21","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/j.1464-410X.2012.11385.x","article-title":"Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention","volume":"110","author":"Zelefsky","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.01.031_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ijrobp.2011.08.034","article-title":"Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer","volume":"83","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2014.01.031_bib23","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1600::AID-CNCR24>3.0.CO;2-0","article-title":"Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma","volume":"79","author":"Neugut","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2014.01.031_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","article-title":"Radiation-induced second cancers: the impact of 3D-CRT and IMRT","volume":"56","author":"Hall","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2014.01.031_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","article-title":"Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors","volume":"10","author":"Travis","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.urology.2014.01.031_bib26","doi-asserted-by":"crossref","first-page":"E319","DOI":"10.1111\/j.1464-410X.2012.11697.x","article-title":"Haematuria after prostate brachytherapy","volume":"111","author":"Leapman","year":"2013","journal-title":"BJU Int"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514001113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514001113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T05:22:15Z","timestamp":1538716935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429514001113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0090429514001113"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2014.01.031","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}